Currently, the only pharmacological intervention following ischemic stroke is tPA, however this therapy is only accessible to a limited number of patients and offers no additional therapeutic benefit beyond the restoration of cerebral blood flow. This evidence concerns the gene PLAT and ischemic stroke.